Goldman Sachs’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Buy |
57,350
+33,884
| +144% | +$251K | ﹤0.01% | 4341 |
|
|
2025
Q1 | $202K | Sell |
23,466
-8,629
| -27% | -$74.3K | ﹤0.01% | 4677 |
|
|
2024
Q4 | $1.15M | Sell |
32,095
-46,274
| -59% | -$1.65M | ﹤0.01% | 3830 |
|
|
2024
Q3 | $3.7M | Buy |
78,369
+28,572
| +57% | +$1.35M | ﹤0.01% | 2968 |
|
|
2024
Q2 | $2.5M | Buy |
49,797
+22,893
| +85% | +$1.15M | ﹤0.01% | 3061 |
|
|
2024
Q1 | $3.01M | Buy |
26,904
+21,081
| +362% | +$2.36M | ﹤0.01% | 2931 |
|
|
2023
Q4 | $338K | Sell |
5,823
-7,659
| -57% | -$444K | ﹤0.01% | 4116 |
|
|
2023
Q3 | $428K | Sell |
13,482
-42,359
| -76% | -$1.34M | ﹤0.01% | 3941 |
|
|
2023
Q2 | $4.59M | Sell |
55,841
-61,741
| -53% | -$5.08M | ﹤0.01% | 2623 |
|
|
2023
Q1 | $12.1M | Buy |
117,582
+37,002
| +46% | +$3.8M | ﹤0.01% | 1868 |
|
|
2022
Q4 | $11.8M | Sell |
80,580
-15,579
| -16% | -$2.28M | ﹤0.01% | 2007 |
|
|
2022
Q3 | $16.3M | Buy |
96,159
+21,745
| +29% | +$3.67M | ﹤0.01% | 1760 |
|
|
2022
Q2 | $8.6M | Buy |
74,414
+8,384
| +13% | +$968K | ﹤0.01% | 2256 |
|
|
2022
Q1 | $6.59M | Buy |
66,030
+17,646
| +36% | +$1.76M | ﹤0.01% | 2586 |
|
|
2021
Q4 | $7.52M | Buy |
48,384
+2,569
| +6% | +$399K | ﹤0.01% | 2489 |
|
|
2021
Q3 | $10.8M | Buy |
45,815
+22,737
| +99% | +$5.36M | ﹤0.01% | 2201 |
|
|
2021
Q2 | $7.84M | Sell |
23,078
-23,218
| -50% | -$7.88M | ﹤0.01% | 2440 |
|
|
2021
Q1 | $18.7M | Buy |
46,296
+4,718
| +11% | +$1.91M | ﹤0.01% | 1727 |
|
|
2020
Q4 | $27.7M | Buy |
41,578
+17,731
| +74% | +$11.8M | 0.01% | 1333 |
|
|
2020
Q3 | $11.1M | Buy |
23,847
+6,553
| +38% | +$3.05M | ﹤0.01% | 1875 |
|
|
2020
Q2 | $10.1M | Buy |
17,294
+13,866
| +404% | +$8.11M | ﹤0.01% | 1938 |
|
|
2020
Q1 | $500K | Buy |
3,428
+856
| +33% | +$125K | ﹤0.01% | 3499 |
|
|
2019
Q4 | $368K | Sell |
2,572
-352
| -12% | -$50.4K | ﹤0.01% | 3784 |
|
|
2019
Q3 | $116K | Buy |
2,924
+1,302
| +80% | +$51.7K | ﹤0.01% | 4028 |
|
|
2019
Q2 | $164K | Buy |
1,622
+652
| +67% | +$65.9K | ﹤0.01% | 3922 |
|
|
2019
Q1 | $128K | Sell |
970
-212
| -18% | -$28K | ﹤0.01% | 3976 |
|
|
2018
Q4 | $121K | Sell |
1,182
-162
| -12% | -$16.6K | ﹤0.01% | 3860 |
|
|
2018
Q3 | $336K | Buy |
1,344
+792
| +143% | +$198K | ﹤0.01% | 3623 |
|
|
2018
Q2 | $247K | Sell |
552
-416
| -43% | -$186K | ﹤0.01% | 3800 |
|
|
2018
Q1 | $381K | Buy |
968
+367
| +61% | +$144K | ﹤0.01% | 3610 |
|
|
2017
Q4 | $247K | Buy |
+601
| New | +$247K | ﹤0.01% | 3734 |
|
|
2017
Q3 | – | Sell |
-2,000
| Closed | -$699K | – | 4350 |
|
|
2017
Q2 | $699K | Buy |
+2,000
| New | +$699K | ﹤0.01% | 3332 |
|